Literature DB >> 27492515

Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Laith Alkukhun1, Xiao-Feng Wang2, Mostafa K Ahmed3, Manfred Baumgartner4, Marie M Budev5, Raed A Dweik6, Adriano R Tonelli7.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is a common complication of idiopathic pulmonary fibrosis (IPF) that is associated with poor prognosis. Noninvasive screening for PH in IPF patients is challenging and a combination of several noninvasive determinations can improve discrimination.
METHODS: We included 235 IPF patients who underwent right heart catheterization (RHC) as part of the lung transplant evaluation. We measured electrocardiographic (ECG) and echocardiographic variables as well as the pulmonary artery (PA) and ascending aorta (AA) diameters on chest CT. We recorded results of arterial blood gases (ABG), pulmonary function (PFT) and 6-min walk tests (6MWT).
RESULTS: Several variables were predictors of PH in IPF patients in univariable models including a lower arterial oxygenation and 6MWT distance; worse right ventricular (RV) function, rightward deviation of the QRS axis and a higher FVC/DLCOc ratio, PA/AA diameter ratio, and estimated RV systolic pressure. In multivariable analysis, a worse RV function and higher PA/AA ratio remained predictors of PH (c-index 0.75 (0.65-0.84)). Similarly, a worse RV function, a higher PA/AA ratio and a rightward QRS axis deviation were independent predictors of precapillary PH (c-index 0.86 (0.76-0.92)). A combination of PA/AA diameter ratio <1.1, a QRS axis <90° and normal RV function showed a negative predictive value of 85% for precapillary PH.
CONCLUSIONS: There are significant differences in ECG, echocardiographic, chest CT, PFT and ABG parameters between IPF patients with and without PH. However, these noninvasive tests alone or combination have limited discrimination ability for PH screening in IPF.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography scan; Echocardiography; Electrocardiogram; Idiopathic pulmonary fibrosis; Pulmonary hypertension

Mesh:

Year:  2016        PMID: 27492515      PMCID: PMC4976395          DOI: 10.1016/j.rmed.2016.06.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  48 in total

1.  Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension.

Authors:  Omar A Minai; Ravi Gudavalli; Srinivas Mummadi; Xiaobo Liu; Kevin McCarthy; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2011-11-22       Impact factor: 21.405

2.  Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  Christopher J Lettieri; Steven D Nathan; Scott D Barnett; Shahzad Ahmad; Andrew F Shorr
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Electrocardiogram in primary pulmonary hypertension--with special reference to prognosis.

Authors:  N Kanemoto
Journal:  Tokai J Exp Clin Med       Date:  1987-09

5.  Electrocardiogram in primary pulmonary hypertension.

Authors:  N Kanemoto
Journal:  Eur J Cardiol       Date:  1981

6.  Pulmonary artery systolic pressures estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation.

Authors:  A Homma; A Anzueto; J I Peters; I Susanto; E Sako; M Zabalgoitia; C L Bryan; S M Levine
Journal:  J Heart Lung Transplant       Date:  2001-08       Impact factor: 10.247

Review 7.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

8.  Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis.

Authors:  Belinda N Rivera-Lebron; Paul R Forfia; Maryl Kreider; James C Lee; John H Holmes; Steven M Kawut
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

9.  Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Authors:  Steven D Nathan; Oksana A Shlobin; Shahzad Ahmad; Jim Koch; Scott D Barnett; Niv Ad; Nelson Burton; Kevin Leslie
Journal:  Respiration       Date:  2008-01-24       Impact factor: 3.580

10.  Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant.

Authors:  A F Shorr; J L Wainright; C S Cors; C J Lettieri; S D Nathan
Journal:  Eur Respir J       Date:  2007-07-11       Impact factor: 16.671

View more
  8 in total

Review 1.  Group 3 Pulmonary Hypertension: From Bench to Bedside.

Authors:  Navneet Singh; Peter Dorfmüller; Oksana A Shlobin; Corey E Ventetuolo
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 2.  Updated Perspectives on Pulmonary Hypertension in COPD.

Authors:  Isabel Blanco; Olga Tura-Ceide; Victor Ivo Peinado; Joan Albert Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-09

3.  Pulmonary hypertension in chronic lung disease and hypoxia.

Authors:  Steven D Nathan; Joan A Barbera; Sean P Gaine; Sergio Harari; Fernando J Martinez; Horst Olschewski; Karen M Olsson; Andrew J Peacock; Joanna Pepke-Zaba; Steeve Provencher; Norbert Weissmann; Werner Seeger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

4.  Accuracy of echocardiography and chest tomography for pulmonary hypertension screening in patients awaiting lung transplantation.

Authors:  Luiza Helena Degani-Costa; João Paulo de Assis; Pedro Paulo Pisaniello Gonçalves; Fernanda Gushken; Gilberto Szarf; José Eduardo Afonso Junior
Journal:  Einstein (Sao Paulo)       Date:  2021-12-20

5.  Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection.

Authors:  Raj Parikh; Ippokratis Konstantinidis; David M O'Sullivan; Harrison W Farber
Journal:  Pulm Circ       Date:  2022-10-01       Impact factor: 2.886

6.  A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease.

Authors:  Simon Bax; Charlene Bredy; Aleksander Kempny; Konstantinos Dimopoulos; Anand Devaraj; Simon Walsh; Joseph Jacob; Arjun Nair; Maria Kokosi; Gregory Keir; Vasileios Kouranos; Peter M George; Colm McCabe; Michael Wilde; Athol Wells; Wei Li; Stephen John Wort; Laura C Price
Journal:  ERJ Open Res       Date:  2018-05-04

Review 7.  Comorbidities and Complications in Idiopathic Pulmonary Fibrosis.

Authors:  Esteban Cano-Jiménez; Fernanda Hernández González; Guadalupe Bermudo Peloche
Journal:  Med Sci (Basel)       Date:  2018-08-30

8.  Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?

Authors:  Małgorzata Sobiecka; Katarzyna Lewandowska; Jarosław Kober; Monika Franczuk; Agnieszka Skoczylas; Witold Tomkowski; Jan Kuś; Monika Szturmowicz
Journal:  Lung       Date:  2020-03-23       Impact factor: 2.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.